InvestorsHub Logo
Followers 20
Posts 1704
Boards Moderated 0
Alias Born 01/02/2003

Re: None

Tuesday, 04/15/2008 6:44:19 PM

Tuesday, April 15, 2008 6:44:19 PM

Post# of 106
Bruker BioSciences "equal weight," target price raised

3:16 p.m. - Lehman Brothers

NEW YORK, April 15 (newratings.com) - Analyst Anthony Butler of Lehman Brothers maintains his "equal weight" rating on Bruker BioSciences Corporation (BRKR), while raising his estimates for the company. The target price has been raised from $15 to $16.

In a research note published this morning, the analyst mentions that the company is likely to post its 1Q total revenues and GAAP EPS at $233.8 million and $0.10, respectively. The Life Science Technology and Diagnostic companies might outperform the S&P 500 Index in the March quarter, the analyst adds. The EPS estimate for FY08 has been raised from $0.53 to $0.57.

http://www.newratings.com/en/main/company_headline.m?id=1729703

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent BRKR News